
    
      The study will randomize between 24 and 72 subjects that received an ALND. A staged adaptive
      design is employed with two intermediate analyses and a final analysis. The first interim
      analysis at 24 treated subjects (at least 12 in each group) and the second at 48 treated
      subjects (at least 24 in each group).
    
  